Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 CTC Enrichment
1.2.3 CTC Detection
1.3 Market by Application
1.3.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals and clinics
1.3.3 Pharmaceuticals and biotechnology companies
1.3.4 Academic research institutes
1.3.5 CROs
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Perspective (2019-2030)
2.2 Circulating Tumor Cell (CTC) Diagnostics Growth Trends by Region
2.2.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Circulating Tumor Cell (CTC) Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Circulating Tumor Cell (CTC) Diagnostics Market Dynamics
2.3.1 Circulating Tumor Cell (CTC) Diagnostics Industry Trends
2.3.2 Circulating Tumor Cell (CTC) Diagnostics Market Drivers
2.3.3 Circulating Tumor Cell (CTC) Diagnostics Market Challenges
2.3.4 Circulating Tumor Cell (CTC) Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cell (CTC) Diagnostics Players by Revenue
3.1.1 Global Top Circulating Tumor Cell (CTC) Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Circulating Tumor Cell (CTC) Diagnostics Revenue
3.4 Global Circulating Tumor Cell (CTC) Diagnostics Market Concentration Ratio
3.4.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cell (CTC) Diagnostics Revenue in 2023
3.5 Circulating Tumor Cell (CTC) Diagnostics Key Players Head office and Area Served
3.6 Key Players Circulating Tumor Cell (CTC) Diagnostics Product Solution and Service
3.7 Date of Enter into Circulating Tumor Cell (CTC) Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Tumor Cell (CTC) Diagnostics Breakdown Data by Type
4.1 Global Circulating Tumor Cell (CTC) Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Type (2025-2030)
5 Circulating Tumor Cell (CTC) Diagnostics Breakdown Data by Application
5.1 Global Circulating Tumor Cell (CTC) Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Circulating Tumor Cell (CTC) Diagnostics Market Size (2019-2030)
6.2 North America Circulating Tumor Cell (CTC) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2019-2024)
6.4 North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size (2019-2030)
7.2 Europe Circulating Tumor Cell (CTC) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2019-2024)
7.4 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size (2019-2030)
9.2 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ApoCell, Inc.(US)
11.1.1 ApoCell, Inc.(US) Company Detail
11.1.2 ApoCell, Inc.(US) Business Overview
11.1.3 ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.1.4 ApoCell, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.1.5 ApoCell, Inc.(US) Recent Development
11.2 Biocep Ltd. (Israel)
11.2.1 Biocep Ltd. (Israel) Company Detail
11.2.2 Biocep Ltd. (Israel) Business Overview
11.2.3 Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.2.4 Biocep Ltd. (Israel) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.2.5 Biocep Ltd. (Israel) Recent Development
11.3 Biocept, Inc.(US)
11.3.1 Biocept, Inc.(US) Company Detail
11.3.2 Biocept, Inc.(US) Business Overview
11.3.3 Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.3.4 Biocept, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.3.5 Biocept, Inc.(US) Recent Development
11.4 Biofluidica MicrotechnologiesLLc(US)
11.4.1 Biofluidica MicrotechnologiesLLc(US) Company Detail
11.4.2 Biofluidica MicrotechnologiesLLc(US) Business Overview
11.4.3 Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.4.4 Biofluidica MicrotechnologiesLLc(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.4.5 Biofluidica MicrotechnologiesLLc(US) Recent Development
11.5 Celltraffix Inc.(US)
11.5.1 Celltraffix Inc.(US) Company Detail
11.5.2 Celltraffix Inc.(US) Business Overview
11.5.3 Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.5.4 Celltraffix Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.5.5 Celltraffix Inc.(US) Recent Development
11.6 ClearbridgeBiomedics(Singapore)
11.6.1 ClearbridgeBiomedics(Singapore) Company Detail
11.6.2 ClearbridgeBiomedics(Singapore) Business Overview
11.6.3 ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.6.4 ClearbridgeBiomedics(Singapore) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.6.5 ClearbridgeBiomedics(Singapore) Recent Development
11.7 Creatv Microtech, Inc.(US)
11.7.1 Creatv Microtech, Inc.(US) Company Detail
11.7.2 Creatv Microtech, Inc.(US) Business Overview
11.7.3 Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.7.4 Creatv Microtech, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.7.5 Creatv Microtech, Inc.(US) Recent Development
11.8 CynvenioBiosystems, Inc.(US)
11.8.1 CynvenioBiosystems, Inc.(US) Company Detail
11.8.2 CynvenioBiosystems, Inc.(US) Business Overview
11.8.3 CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.8.4 CynvenioBiosystems, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.8.5 CynvenioBiosystems, Inc.(US) Recent Development
11.9 EpicBiosciencesInc.(US)
11.9.1 EpicBiosciencesInc.(US) Company Detail
11.9.2 EpicBiosciencesInc.(US) Business Overview
11.9.3 EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.9.4 EpicBiosciencesInc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.9.5 EpicBiosciencesInc.(US) Recent Development
11.10 FluxionBiosciences, Inc.(US)
11.10.1 FluxionBiosciences, Inc.(US) Company Detail
11.10.2 FluxionBiosciences, Inc.(US) Business Overview
11.10.3 FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.10.4 FluxionBiosciences, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.10.5 FluxionBiosciences, Inc.(US) Recent Development
11.11 Ikonisys, Inc.(US)
11.11.1 Ikonisys, Inc.(US) Company Detail
11.11.2 Ikonisys, Inc.(US) Business Overview
11.11.3 Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.11.4 Ikonisys, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.11.5 Ikonisys, Inc.(US) Recent Development
11.12 IVDiagnostics, Inc.(US)
11.12.1 IVDiagnostics, Inc.(US) Company Detail
11.12.2 IVDiagnostics, Inc.(US) Business Overview
11.12.3 IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.12.4 IVDiagnostics, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.12.5 IVDiagnostics, Inc.(US) Recent Development
11.13 JanssenDiagnosticsLLc(US)
11.13.1 JanssenDiagnosticsLLc(US) Company Detail
11.13.2 JanssenDiagnosticsLLc(US) Business Overview
11.13.3 JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.13.4 JanssenDiagnosticsLLc(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.13.5 JanssenDiagnosticsLLc(US) Recent Development
11.14 QIAGEnHannoverGmbH (Germany)
11.14.1 QIAGEnHannoverGmbH (Germany) Company Detail
11.14.2 QIAGEnHannoverGmbH (Germany) Business Overview
11.14.3 QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.14.4 QIAGEnHannoverGmbH (Germany) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.14.5 QIAGEnHannoverGmbH (Germany) Recent Development
11.15 RARECELLsSAs(Italy)
11.15.1 RARECELLsSAs(Italy) Company Detail
11.15.2 RARECELLsSAs(Italy) Business Overview
11.15.3 RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.15.4 RARECELLsSAs(Italy) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.15.5 RARECELLsSAs(Italy) Recent Development
11.16 ScreenCell(France)
11.16.1 ScreenCell(France) Company Detail
11.16.2 ScreenCell(France) Business Overview
11.16.3 ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.16.4 ScreenCell(France) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.16.5 ScreenCell(France) Recent Development
11.17 STEMCELlTechnologies, Inc.(Canada)
11.17.1 STEMCELlTechnologies, Inc.(Canada) Company Detail
11.17.2 STEMCELlTechnologies, Inc.(Canada) Business Overview
11.17.3 STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.17.4 STEMCELlTechnologies, Inc.(Canada) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2019-2024)
11.17.5 STEMCELlTechnologies, Inc.(Canada) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details